ISDA

Entry Detail

PDB ID:

7OVD

Keywords:

SIGNALING PROTEIN

Title:

Human soluble adenylyl cyclase in complex with the inhibitor TDI10229

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Trichoplusia ni

PDB Version:

Deposition Date:

2021-06-14

Release Date:

2021-10-06

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.20 Å

R-Value Free:

0.24

R-Value Work:

0.19

R-Value Observed:

0.20

Space Group:

P 63

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Adenylate cyclase type 10
Chain IDs:A
Chain Length:475
Number of Molecules:1
Biological Source:Homo sapiens

UniProt ID:Q96PN6 Pfam ID:PF00211 EC:4.6.1.1

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
CME	A	CYS	modified residue

Ligand Molecules

1S2

ACT

DMS

EDO

Primary Citation

Discovery of TDI-10229: A Potent and Orally Bioavailable Inhibitor of Soluble Adenylyl Cyclase (sAC, ADCY10).

Fushimi, M, Buck, H, Balbach, M, Gorovyy, A, Ferreira, J, Rossetti, T, Kaur, N, Levin, L.R, Buck, J, Quast, J, van den Heuvel, J, Steegborn, C, Finkin-Groner, E, Kargman, S, Michino, M, Foley, M.A, Miller, M, Liverton, N.J, Huggins, D.J, Meinke, P.T.Show

Acs Med.Chem.Lett. 12 1283 1287 (2021)

PMID: 34413957 DOI: 10.1021/acsmedchemlett.1c00273

Abstact

Soluble adenylyl cyclase (sAC) has gained attention as a potential therapeutic target given the role of this enzyme in intracellular signaling. We describe successful efforts to design improved sAC inhibitors amenable for in vivo interrogation of sAC inhibition to assess its potential therapeutic applications. This work culminated in the identification of TDI-10229 (12), which displays nanomolar inhibition of sAC in both biochemical and cellular assays and exhibits mouse pharmacokinetic properties sufficient to warrant its use as an in vivo tool compound.

Legend

Protein

Chemical

Disease

Primary Citation of related structures